RPRX insider trading — Royalty Pharma plc
No open-market insider purchases or sales were filed for Royalty Pharma plc (RPRX) in the last 90 days. Other insider transactions — such as stock awards, option exercises or tax withholding — are listed below.
Updated Oct 16, 2026.
Recent RPRX insider transactions
Every Form 4 filed by Royalty Pharma plc officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Urist Marshall | EVP, Research & Investments | S · Sale · 10b5-1 | Direct | 4,126 | $57.10 | $236K | Form 4 |
| Sep 30, 2026 | Bassler Bonnie L | Director | A · Grant/award | Direct | 642 | $58.41 | $37K | Form 4 |
| Sep 28, 2026 | Urist Marshall | EVP, Research & Investments | S · Sale · 10b5-1 | Direct | 4,126 | $57.88 | $239K | Form 4 |
| Sep 22, 2026 | Hite Christopher | EVP & Chairman, Partnering | S · Sale · 10b5-1 | Indirect | 100,000 | $58.53 | $5.85M | Form 4 |
| Aug 19, 2026 | Hite Christopher | EVP & Chairman, Partnering | G · Gift · 10b5-1 | Direct | 16,800 | — | — | Form 4 |
| Aug 18, 2026 | Hite Christopher | EVP & Chairman, Partnering | S · Sale · 10b5-1 | Indirect | 100,000 | $59.97 | $6.00M | Form 4 |
| Aug 13, 2026 | Coyne Terrance P. | EVP & CFO | S · Sale · 10b5-1 | Indirect | 11,002 | $58.68 | $646K | Form 4 |
| Aug 5, 2026 | Legorreta Pablo G. | CEO, Chairman of the Board | A · Grant/award | Direct | 65,216 | — | — | Form 4 |
| Aug 5, 2026 | Coyne Terrance P. | EVP & CFO | A · Grant/award | Indirect | 11,002 | — | — | Form 4 |
| Aug 5, 2026 | Hite Christopher | EVP & Chairman, Partnering | A · Grant/award | Indirect | 11,002 | — | — | Form 4 |
| Aug 5, 2026 | Urist Marshall | EVP, Research & Investments | A · Grant/award | Direct | 8,252 | — | — | Form 4 |
RPRX insider trading FAQ
Are insiders buying RPRX stock?
Not on the open market. In the last 90 days, Royalty Pharma plc insiders made no open-market purchases, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading RPRX?
No insider bought or sold on the open market in the last 90 days.
Where does RPRX insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.